Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Nkarta Therapeutics (United States) | Researchclopedia

Back to institutions

Nkarta Therapeutics (United States)

South San Francisco, Californiacompany

66

Works

3,150

Citations

23

h-index

Top Research Topics

CAR-T cell therapy research Immune Cell Function and Interaction Liver Disease and Transplantation

Top Researchers

Jill A. Helms Stanford University

279 works26,145 citationsh-index: 75

Recent Research

558 Single cell RNA and TCR sequencing reveal candidate immune biomarkers of NKX019 clinical response in non-Hodgkin lymphoma (NHL)

Katharine Yu,Jessica Wei,et al.

20250 citations

HIV Research and Treatment

Hepatitis C virus research

Cancer Immunotherapy and Biomarkers

Liver Disease Diagnosis and Treatment

HIV/AIDS drug development and treatment

dental development and anomalies

Acute Myeloid Leukemia Research

Liver physiology and pathology

Monoclonal and Polyclonal Antibodies Research

Qi Zhang Wannan Medical College

1,036 works25,212 citationsh-index: 79

Chang H. Kim University of Michigan

314 works20,148 citationsh-index: 71

Paul D. Hastings University of California, Davis

298 works16,920 citationsh-index: 59

Éric Lefebvre Université Paris Cité

233 works9,533 citationsh-index: 46

Xiumin Wu Hunan Normal University

186 works7,196 citationsh-index: 34

229 CRISPR/Cas9-mediated MED12 gene knockout enhances the cytotoxicity, adaptive features, and TGF-β resistance of human CAR NK cells

Chao Guo,Kyle Pratt,et al.

20250 citations

Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective

Elena W.Y. Hsieh,James Chung,et al.

20250 citations

A Phase 1 Study of NKX019, an Allogeneic Chimeric Antigen Receptor Natural Killer (CAR-NK) Cell Therapy in Patients with Systemic Lupus Erythematosus

Anca Askanase,Leila Khalili,et al.

20248 citations

Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid Tumors

Amy E. Anderson,Kaustubh Parashar,et al.

20248 citations

Abstract 3603: NKX101, an allogeneic off-the-shelf CAR NK cell therapy targeting NKG2D-Ls, has potent anti-leukemic activity alone or in combination with Ara-C

Cynthia Cho,Nikki Kimura,et al.

20240 citations